Anne‐Lise Børresen‐Dale

27.6k total citations · 1 hit paper
26 papers, 12.4k citations indexed

About

Anne‐Lise Børresen‐Dale is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Anne‐Lise Børresen‐Dale has authored 26 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Anne‐Lise Børresen‐Dale's work include Cancer Genomics and Diagnostics (10 papers), Gene expression and cancer classification (6 papers) and Breast Cancer Treatment Studies (5 papers). Anne‐Lise Børresen‐Dale is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Gene expression and cancer classification (6 papers) and Breast Cancer Treatment Studies (5 papers). Anne‐Lise Børresen‐Dale collaborates with scholars based in Norway, United States and United Kingdom. Anne‐Lise Børresen‐Dale's co-authors include Thérese Sørlie, Hilde Johnsen, Per Eystein Lønning, Charles M. Perou, Christian A. Rees, Patrick O. Brown, David Botstein, Michael B. Eisen, Jonathan R. Pollack and Øystein Fluge and has published in prestigious journals such as Nature, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Anne‐Lise Børresen‐Dale

25 papers receiving 12.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular portraits of human breast tumours

2000 11.7k citations Charles M. Perou, Thérese Sørlie et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne‐Lise Børresen‐Dale Norway	18	6.3k	6.1k	6.0k	1.7k	1.7k	26	12.4k
Øystein Fluge Norway	25	6.5k 1.0×	6.1k 1.0×	6.4k 1.1×	1.9k 1.1×	1.7k 1.0×	91	13.9k
Yasuo Toyozumi Japan	14	5.2k 0.8×	5.5k 0.9×	5.8k 1.0×	2.2k 1.3×	1.5k 0.9×	37	11.8k
Rumiko Tashima Japan	10	5.1k 0.8×	5.4k 0.9×	5.6k 0.9×	2.1k 1.2×	1.5k 0.9×	21	11.5k
Mamiko Fujisue Japan	11	5.1k 0.8×	5.4k 0.9×	5.5k 0.9×	2.1k 1.2×	1.5k 0.9×	18	11.4k
Tomofumi Osako Japan	19	5.2k 0.8×	5.7k 0.9×	6.0k 1.0×	2.2k 1.3×	1.6k 1.0×	42	12.1k
Philip S. Bernard United States	36	5.0k 0.8×	5.6k 0.9×	5.2k 0.9×	1.8k 1.0×	1.3k 0.8×	91	11.2k
Stephanie Geisler Norway	21	7.5k 1.2×	7.2k 1.2×	7.4k 1.2×	1.7k 1.0×	2.5k 1.5×	36	14.5k
Turid Aas Norway	28	5.7k 0.9×	5.3k 0.9×	5.7k 1.0×	1.3k 0.8×	2.0k 1.2×	59	11.5k
Reiki Nishimura Japan	27	5.4k 0.9×	6.2k 1.0×	6.8k 1.1×	2.6k 1.5×	1.8k 1.1×	131	13.3k
Yasuyuki Nishiyama Japan	16	5.4k 0.9×	5.4k 0.9×	5.7k 0.9×	2.2k 1.3×	1.5k 0.9×	38	12.0k

Countries citing papers authored by Anne‐Lise Børresen‐Dale

Since Specialization

Citations

This map shows the geographic impact of Anne‐Lise Børresen‐Dale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Lise Børresen‐Dale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Lise Børresen‐Dale more than expected).

Fields of papers citing papers by Anne‐Lise Børresen‐Dale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Lise Børresen‐Dale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Lise Børresen‐Dale. The network helps show where Anne‐Lise Børresen‐Dale may publish in the future.

Co-authorship network of co-authors of Anne‐Lise Børresen‐Dale

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Lise Børresen‐Dale. A scholar is included among the top collaborators of Anne‐Lise Børresen‐Dale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Lise Børresen‐Dale. Anne‐Lise Børresen‐Dale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Castro-Mondragón, Jaime A., Miriam R. R. Aure, Ole Christian Lingjærde, et al.. (2022). Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers. Nucleic Acids Research. 50(21). 12131–12148. 10 indexed citations

Nygård, Ståle, Ole Christian Lingjærde, Carlos Caldas, et al.. (2019). PathTracer: High-sensitivity detection of differential pathway activity in tumours. Scientific Reports. 9(1). 16332–16332. 2 indexed citations

Höglander, Elen, Silje Nord, David C. Wedge, et al.. (2018). Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. Genome Medicine. 10(1). 92–92. 18 indexed citations

Ree, Anne Hansen, Kjersti Flatmark, Vigdis Nygaard, et al.. (2018). Abstract A101: The MetAction trial: long-lasting responses to molecularly matched therapy in end-stage cancer. Molecular Cancer Therapeutics. 17(1_Supplement). A101–A101.

Østrup, Oľga, Vegar Johansen Dagenborg, Einar Andreas Rødland, et al.. (2017). Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases. Oncotarget. 8(44). 76290–76304. 25 indexed citations

Zänker, Kurt S., et al.. (2016). Personalized Cancer Care: Risk Prediction, Early Diagnosis, Progression, and Therapy. PubMed. 1(3). 1–9. 2 indexed citations

Bjaanæs, Maria Moksnes, Ann Rita Halvorsen, Steinar Solberg, et al.. (2014). Unique microRNA‐profiles in EGFR ‐mutated lung adenocarcinomas. International Journal of Cancer. 135(8). 1812–1821. 54 indexed citations

Viken, Marte K., Anders Erik Astrup Dahm, Hans Kristian Moen Vollan, et al.. (2014). Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCRgenes are associated with breast cancer: a case-control study. BMC Cancer. 14(1). 845–845. 34 indexed citations

Lothe, Inger Marie Bowitz, Knut Jørgen Labori, Ole Christian Lingjærde, et al.. (2014). Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas. Molecular Oncology. 9(4). 758–771. 32 indexed citations

10.

Zhao, Xi, Einar Andreas Rødland, Thérese Sørlie, et al.. (2014). Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status. BMC Cancer. 14(1). 211–211. 31 indexed citations

11.

Baumbusch, Lars O., Åslaug Helland, Yun Wang, et al.. (2013). High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival. PLoS ONE. 8(1). e54356–e54356. 17 indexed citations

12.

Liu, Yanhong, Renke Zhou, Lars O. Baumbusch, et al.. (2013). Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer. Breast Cancer Research and Treatment. 143(1). 189–201. 8 indexed citations

13.

Mathiesen, Randi R., Knut Liestøl, Eldri U. Due, et al.. (2011). High‐resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer. International Journal of Cancer. 131(4). E405–15. 44 indexed citations

14.

Haakensen, Vilde Drageset, Ole Christian Lingjærde, Torben Lüders, et al.. (2011). Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features. BMC Medical Genomics. 4(1). 77–77. 29 indexed citations

15.

Borgan, Eldrid, Beathe Sitter, Ole Christian Lingjærde, et al.. (2010). Merging transcriptomics and metabolomics - advances in breast cancer profiling. BMC Cancer. 10(1). 92 indexed citations

16.

Haakensen, Vilde Drageset, Ole Christian Lingjærde, Marit Muri Holmen, et al.. (2010). Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density. Breast Cancer Research. 12(4). R65–R65. 38 indexed citations

17.

Kristensen, Vessela N., Thérese Sørlie, Jürgen Geisler, et al.. (2005). Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications. Clinical Cancer Research. 11(2). 878s–883s. 25 indexed citations

18.

Benetkiewicz, Magdalena, Yun Wang, Marci E. Schaner, et al.. (2004). High‐resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas. Genes Chromosomes and Cancer. 42(3). 228–237. 24 indexed citations

19.

Perou, Charles M., Thérese Sørlie, Michael B. Eisen, et al.. (2000). Molecular portraits of human breast tumours. Nature. 406(6797). 747–752. 11684 indexed citations breakdown →

20.

Andersen, Tone Ikdahl, Richard Wooster, Nadine Collins, et al.. (1997). Screening for ESR mutations in breast and ovarian cancer patients. Human Mutation. 9(6). 531–536. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact